These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 17596891

  • 1. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
    Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J.
    Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891
    [Abstract] [Full Text] [Related]

  • 2. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
    Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, Sauerbruch T, Heller J.
    Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
    [Abstract] [Full Text] [Related]

  • 3. Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats.
    Liu J, Peng L, Yang J, Wang M, Xu S, Liu J, Han P, He J, Tian D, Zhou Q.
    Dig Dis Sci; 2015 Jul; 60(7):2019-29. PubMed ID: 25724163
    [Abstract] [Full Text] [Related]

  • 4. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, Schmidt M, Jakobs KH, Sauerbruch T, Heller J.
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [Abstract] [Full Text] [Related]

  • 5. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E, Rodríguez-Vilarrupla A, Gracia-Sancho J, Tripathi D, García-Calderó H, Bosch J, García-Pagán JC.
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M, Rodriguez S, Raurell I, Ezkurdia N, Brull A, Augustin S, Guardia J, Esteban R, Martell M, Genescà J.
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
    Hennenberg M, Trebicka J, Buecher D, Heller J, Sauerbruch T.
    Liver Int; 2009 Jul; 29(6):933-41. PubMed ID: 19490424
    [Abstract] [Full Text] [Related]

  • 10. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J.
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
    Trebicka J, Leifeld L, Hennenberg M, Biecker E, Eckhardt A, Fischer N, Pröbsting AS, Clemens C, Lammert F, Sauerbruch T, Heller J.
    Hepatology; 2008 Apr; 47(4):1264-76. PubMed ID: 18318439
    [Abstract] [Full Text] [Related]

  • 12. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.
    Klein S, Van Beuge MM, Granzow M, Beljaars L, Schierwagen R, Kilic S, Heidari I, Huss S, Sauerbruch T, Poelstra K, Trebicka J.
    J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469
    [Abstract] [Full Text] [Related]

  • 13. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ, Qiu JF, Luo M, Sun YW, Zhao G, Chen W, Liu H, Wu ZY.
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [Abstract] [Full Text] [Related]

  • 14. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G, Kawanaka H, Yoshida D, Konishi K, Yamaguchi S, Kinjo N, Taketomi A, Hashizume M, Shimokawa H, Maehara Y.
    Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
    [Abstract] [Full Text] [Related]

  • 15. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
    Morelli A, Vignozzi L, Filippi S, Vannelli GB, Ambrosini S, Mancina R, Crescioli C, Donati S, Fibbi B, Colli E, Adorini L, Maggi M.
    Prostate; 2007 Feb 15; 67(3):234-47. PubMed ID: 17163492
    [Abstract] [Full Text] [Related]

  • 16. Amiloride reduces portal hypertension in rat liver cirrhosis.
    Steib CJ, Hennenberg M, Beitinger F, Hartmann AC, Bystron M, De Toni EN, Gerbes AL.
    Gut; 2010 Jun 15; 59(6):827-36. PubMed ID: 20551467
    [Abstract] [Full Text] [Related]

  • 17. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L, Filippi S, Chavalmane A, Silvestrini E, Colli E, Adorini L, Vannelli GB, Maggi M.
    J Androl; 2008 Jun 15; 29(1):70-84. PubMed ID: 17699803
    [Abstract] [Full Text] [Related]

  • 18. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
    Iizuka M, Murata T, Hori M, Ozaki H.
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun 15; 300(6):G1010-21. PubMed ID: 21393429
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats.
    Ito D, Ito O, Mori N, Muroya Y, Cao PY, Takashima K, Kanazawa M, Kohzuki M.
    J Hypertens; 2010 Nov 15; 28(11):2278-88. PubMed ID: 20724941
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
    Kageyama Y, Ikeda H, Watanabe N, Nagamine M, Kusumoto Y, Yashiro M, Satoh Y, Shimosawa T, Shinozaki K, Tomiya T, Inoue Y, Nishikawa T, Ohtomo N, Tanoue Y, Yokota H, Koyama T, Ishimaru K, Okamoto Y, Takuwa Y, Koike K, Yatomi Y.
    Hepatology; 2012 Oct 15; 56(4):1427-38. PubMed ID: 22505286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.